Thought leadership pieces from subject matter experts inside of Fresenius Medical Care North America
Fresenius Medical Care North America (FMCNA) is in the ideal position to drive innovation and compress the time it takes to translate science into patient care standards.
whitepaper
As the number of medically needy patients with ESRD increases, the clinic team has less time to analyze an ever-increasing amount of valuable data on patient outcomes.
whitepaper
The emerging field regenerative medicine holds both immediate and long-term promise for patients with ESRD.
whitepaper
Shorter, more frequent dialysis treatments can help improve cardiovascular complications and quality of life for end-stage renal disease (ESRD) patients.
whitepaper
Family members and friends often play a significant role as caregivers for people with end-stage renal disease (ESRD) and other chronic conditions.
whitepaper
Fresenius Medical Care North America (FMCNA) takes a strategic and comprehensive approach to disaster management.
whitepaper
As the leader in value-based care (VBC) for patients with end-stage renal disease (ESRD), Fresenius Medical Care North America (FMCNA) is in an ideal position to drive health care innovation.
whitepaper
Fresenius Medical Care North America (FMCNA) has established an antibiotic stewardship program to help minimize the unintended consequences of antibiotic use in patients with end-stage renal disease (ESRD).
whitepaper
Despite the pressing need to bring novel therapies to patients with renal impairments, the development time and cost to bring new drugs and medical devices to market has actually increased over the past decade.
whitepaper
Fresenius Kidney Care (FKC) has been studying the real-world effectiveness of Velphoro to see if a lower pill burden helps patients increase adherence and reduce their serum phosphorus levels.
whitepaper
Due to high pill burden and gastrointestinal side effects, patient adherence to daily intake of cinacalcet is limited.
whitepaper
As technology continues to improve, our ability to aggregate and gain actionable insight from diverse data sources is increasing dramatically.
whitepaper